benzbromarone has been researched along with Cataract, Membranous in 1 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the effects of colchicine, allopurinol and benzbromarone on the risk of cataract in patients with gout." | 3.91 | Association of gout medications and risk of cataract: a population-based case-control study. ( Li, YJ; Perng, WT; Tseng, KY; Wang, YH; Wei, JC, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, YJ | 1 |
| Perng, WT | 1 |
| Tseng, KY | 1 |
| Wang, YH | 1 |
| Wei, JC | 1 |
1 other study available for benzbromarone and Cataract, Membranous
| Article | Year |
|---|---|
Association of gout medications and risk of cataract: a population-based case-control study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Allopurinol; Benzbromarone; Case-Control Studies; Catar | 2019 |